The outstanding record of clinical trials in the British Journal of Dermatology

British Journal of Dermatology

Volumn 170, Issue 4, 2014, Pages 761-763

  Williams, H ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKLIST; CLINICAL TRIAL (TOPIC); DERMATOLOGY; EDITORIAL; HUMAN; MEDICAL LITERATURE; MEDICAL RECORD; MEDICAL RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); PUBLICATION; STATISTICS AND NUMERICAL DATA;

CLINICAL TRIALS AS TOPIC; DERMATOLOGY; HUMANS; PERIODICALS AS TOPIC;

EID: 84929939404     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13011     Document Type: Editorial

References (20)

1. Williams HC, Dellavalle RP,. The growth of clinical trials and systematic reviews in informing dermatological patient care. J Invest Dermatol 2012; 132: 1008-17.
2. A Medical Research Council investigation. Streptomycin treatment of pulmonary tuberculosis. Br Med J 1948; 2: 769-82.
3. Adetugbo K, Williams H,. How well are randomized controlled trials reported in the dermatology literature? Arch Dermatol 2000; 136: 381-5.
4. Naldi N, Svensson A, Diepgen T, et al,. Randomized clinical trials for psoriasis 1987-2000: the EDEN survey. J Invest Dermatol 2003; 120: 738-41.
5. van Coevorden AM, Coenraads PJ, Svensson A, et al,. Overview of therapeutic studies of treatment for hand eczema-the EDEN hand eczema survey. Br J Dermatol 2004; 151: 446-51.
6. Alvarez F, Meyer N, Gourraud PA, Paul C,. CONSORT adoption and quality of reporting of randomized controlled trials: a systematic analysis in two dermatology journals. Br J Dermatol 2009; 161: 1159-65.
7. Naldi L, Svensson A, Zenoni D, et al,. Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis: update of the EDEN Psoriasis Survey 2001-2006. Br J Dermatol 2010; 162: 384-9.
8. Thomas KS, Crook AM, Nunn AJ, et al,. Penicillin to prevent leg cellulitis recurrence. N Engl J Med 2013; 368: 1695-703.
9. Saurat JH, Stingl G, Dubertret L, et al,. Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). Br J Dermatol 2008; 158: 558-66.
10. Ruzicka T, Lynde CW, Jemec GB, et al,. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008; 158: 808-17.
11. Morton CA, Whitehurst C, Moseley H, et al,. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 1996; 135: 766-71.
12. Cox N, Williams HC,. Can you COPE with CONSORT? Br J Dermatol 2000; 142: 1-7.
13. Williams HC,. Cars, CONSORT 2010, and clinical practice. Trials 2010; 11: 33.
14. Whitton ME, Pinart M, Batchelor J, et al,. Interventions for vitiligo. Cochrane Database Syst Rev 2010; 1: CD003263.
15. Rigopoulos D, Gregoriou S, Belyayeva E, et al,. Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblinded randomized study. Br J Dermatol 2009; 160: 858-60.
16. Wiley Online Library. Virtual issues. Randomised controlled trials. Br J Dermatol. Available at: http://onlinelibrary.wiley.com/journal/10.1111/ %28ISSN%291365-2133/homepage/VirtualIssuesPage.html (last accessed 24 February 2014).
17. Chan AW, Hrõbjartsson A, Haahr MT, et al,. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004; 291: 2457-65.
18. Nankervis H, Baibergenova A, Williams HC, Thomas KS,. Prospective registration and outcome-reporting bias in randomized controlled trials of eczema treatments: a systematic review. J Invest Dermatol 2012; 132: 2727-34.
19. Ormerod AD, Williams HC,. Compulsory registration of trials. Br J Dermatol 2005; 152: 859-60.
20. Williams HC, Goldsmith L,. The JID opens its doors to high-quality randomized controlled clinical trials. J Invest Dermatol 2006; 126: 1683-4.